Home › Funds › Cairn Investment Group, Inc. › GILD

Cairn Investment Group, Inc. position in GILD

GILEAD SCIENCES INC · Health Care

Cairn Investment Group, Inc. reported holding 21,122 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$3.1M, representing 1.34% of its reported portfolio and ranking #27 among its reported holdings. Cairn Investment Group, Inc. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)21.12K sh
Reported value held$3.15M
Portfolio Weight1.34%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Cairn Investment Group, Inc.'s GILD position evolved

Cairn Investment Group, Inc. first disclosed a stake in GILD in Q3 2023 at 23,118 shares (US$1.7M). The position peaked in Q3 2026 at 21,122 shares, worth US$3.1M. Across 13 filings, Cairn Investment Group, Inc. increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 21,122 shares valued at US$3.1M — a reduction of -125 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 23.12K $1.73M New
Q4 2023 24.47K $1.98M Add
Q1 2024 24.27K $1.78M Reduce
Q2 2024 22.82K $1.57M Reduce
Q3 2024 22.34K $1.87M Reduce
Q4 2024 22.28K $2.06M Hold
Q1 2025 22.12K $2.48M Reduce
Q2 2025 22.28K $2.47M Add
Q3 2025 21.78K $2.42M Reduce
Q4 2025 21.75K $2.67M Hold
Q1 2026 21.36K $2.98M Reduce
Q2 2026 21.25K $2.68M Reduce
Q3 2026 21.12K $3.15M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Cairn Investment Group, Inc. held GILD?

Cairn Investment Group, Inc. has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Cairn Investment Group, Inc.'s current position in GILD?

As of Q3 2026, Cairn Investment Group, Inc. holds 21.12K shares of GILD (GILEAD SCIENCES INC), valued at $3.15M, representing 1.34% of its reported portfolio and ranking #27.

Has Cairn Investment Group, Inc. been buying or selling GILD?

In the latest 13F filing (Q3 2026), Cairn Investment Group, Inc. reduced its position in GILD. The position peaked in Q3 2026 at 21.12K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.